Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Duerr

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
The Lancet. Microbe|May 11, 2022
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical studyMarta Massanella, Rachel A Bender Ignacio, Javier R Lama, et al.
Lancet Regional Health. Americas|February 13, 2023
Finding and treating early-stage HIV infections: A cost-effectiveness analysis of the <i>Sabes</i> study in Lima, PeruAngela K Ulrich, Blythe J Adamson, Enrique M Saldarriaga, et al.
The Lancet. Microbe|November 29, 2021
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical studyMarta Massanella, Rachel A Bender Ignacio, Javier R Lama, et al.
Obstetrics and Gynecology|May 27, 2010
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral sheddingRegan N Theiler, Sherry L Farr, John M Karon, et al.
AIDS (London, England)|February 13, 2023
Acute retroviral syndrome is associated with lower CD4 + T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiationRose Gabert, Javier R Lama, Rogelio Valdez, et al.
AIDS Care|May 20, 2021
Linkage to care after HIV diagnosis among men who have sex with men and transgender women in Lima, PeruAngela D Primbas, Edward White, Jessica E Long, et al.
Plos Pathogens|March 9, 2011
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I allelesStephen A Migueles, Julia E Rood, Amy M Berkley, et al.
Frontiers in Immunology|October 9, 2025
Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responsesWilbert Mbuya, Augusta Horvath, Kathrin Held, et al.
AIDS (London, England)|December 15, 2010
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control studyMarcel E Curlin, Farah Cassis-Ghavami, Amalia S Magaret, et al.
The Journal of Infectious Diseases|December 11, 2023
Viral Load Dynamics in Plasma and Semen When Antiretroviral Therapy Is Initiated During Early HIV-1 InfectionTrupti Gilada, Angela K Ulrich, Yixin Wang, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
The Lancet. Microbe|May 11, 2022
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical studyMarta Massanella, Rachel A Bender Ignacio, Javier R Lama, et al.
Lancet Regional Health. Americas|February 13, 2023
Finding and treating early-stage HIV infections: A cost-effectiveness analysis of the <i>Sabes</i> study in Lima, PeruAngela K Ulrich, Blythe J Adamson, Enrique M Saldarriaga, et al.
The Lancet. Microbe|November 29, 2021
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical studyMarta Massanella, Rachel A Bender Ignacio, Javier R Lama, et al.
Obstetrics and Gynecology|May 27, 2010
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral sheddingRegan N Theiler, Sherry L Farr, John M Karon, et al.
AIDS (London, England)|February 13, 2023
Acute retroviral syndrome is associated with lower CD4 + T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiationRose Gabert, Javier R Lama, Rogelio Valdez, et al.
AIDS Care|May 20, 2021
Linkage to care after HIV diagnosis among men who have sex with men and transgender women in Lima, PeruAngela D Primbas, Edward White, Jessica E Long, et al.
Plos Pathogens|March 9, 2011
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I allelesStephen A Migueles, Julia E Rood, Amy M Berkley, et al.
Frontiers in Immunology|October 9, 2025
Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responsesWilbert Mbuya, Augusta Horvath, Kathrin Held, et al.
AIDS (London, England)|December 15, 2010
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control studyMarcel E Curlin, Farah Cassis-Ghavami, Amalia S Magaret, et al.
The Journal of Infectious Diseases|December 11, 2023
Viral Load Dynamics in Plasma and Semen When Antiretroviral Therapy Is Initiated During Early HIV-1 InfectionTrupti Gilada, Angela K Ulrich, Yixin Wang, et al.
Pageof 14